(Q44516849)

3 December 2017

title

Treatment of human brucellosis with rifampin plus minocycline (English)

1 reference

3 December 2017

1 reference

Cascio A

1

1 reference

3 December 2017

Scarlata F

2

1 reference

3 December 2017

Giordano S

3

1 reference

3 December 2017

Antinori S

4

1 reference

3 December 2017

Colomba C

5

1 reference

3 December 2017

Titone L

6

1 reference

3 December 2017

language of work or name

1 reference

1 June 2003

1 reference

3 December 2017

published in

Journal of Chemotherapy

1 reference

3 December 2017

volume

15

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

248-252

1 reference

An overview of human brucellosis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

Brucellosis treated with rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

Metabolism and tissue distribution of radioisotopically labeled minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

The biogenesis of lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

Minocycline-induced pigmentation. Incidence, prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.248

10.1179/JOC.2003.15.3.248

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference